KKR Takes Strategic Stake in Medical Supplier Henry Schein (1)

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.

US private equity firm KKR will become the largest non-index fund shareholder in the group and also has the option to increase its stake to up to nearly 15%, according to a statement Wednesday.

As part of the deal, two KKR representatives — Max Lin and William K. Daniel— will join the board of Henry Schein as independent directors. Lin leads KKR’s health-care ...